Compliance Diversity Finance Pharmaceuticals 
Harvard Business Review
JUNE 8, 2015
Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.
Harvard Business Review
OCTOBER 24, 2014
So instead of creating another pill dispenser, it launched a compliance-enhancing system. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers.
Expert insights. Personalized for you.
8 
Let's personalize your content